HYPERTENSION DIAGNOSTICS, INC. Inactive Instrument
Hypertension Diagnostics, Inc. Stock Other OTC
Equities
HDII
US44914V1044
Advanced Medical Equipment & Technology
Financials (USD)
| Sales 2017 | 3.68M | Sales 2018 | 3.79M | Capitalization | 92.08K |
|---|---|---|---|---|---|
| Net income 2017 | - | Net income 2018 | - | EV / Sales 2017 | 1.15 x |
| Net Debt 2017 | 4.13M | Net Debt 2018 | 4.6M | EV / Sales 2018 | 1.24 x |
| P/E ratio 2017 |
-0.28
x | P/E ratio 2018 |
-0.54
x | Employees | - |
| Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Liangjian Peng
CEO | Chief Executive Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Liangjian Peng
CEO | Chief Executive Officer | - | - |
Hypertension Diagnostics, Inc. is a shell company. The Company, through its subsidiary, China Specialty International Limited, focuses on brand licensing, distribution authorization and investment related to these registered brands and trademarks in provincial-level, city-level, country-level administrative regions in China.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.02% | 207B | |
| +2.17% | 175B | |
| +10.45% | 132B | |
| +16.62% | 99.1B | |
| -2.70% | 60.89B | |
| +13.38% | 52.04B | |
| -6.33% | 45.48B | |
| -4.74% | 38.81B | |
| +9.89% | 38.77B |
